PYMNTS.com January 19, 2025

Will 2025 bring an end to a fallow period for medical device company IPOs?

As the Financial Times (FT) reported Sunday (Jan. 19) a pair of initial public offerings (IPO) by cardiac device makers could be a sign that a dearth in medical tech listings is soon to end.

Sources told the FT that Kestra Medical Technologies and Heartflow, which both make non-invasive cardiac tests for patients with heart conditions, have recently hired advisers to prepare for IPOs. These listings could happen as soon as the first half of the year, one source said.

The report said high interest rates and a lackluster performance by other medical companies that went public during the pandemic has led investors to cool on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Trends
New AFib treatments show promise
FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care
BD to expand production of critical medical devices
Boston Scientific to acquire Bolt Medical for up to $664 million
Is Medtronic On the Cusp of Rewriting Its Own Story in Renal Denervation?

Share This Article